{"id":"8ae8896e-4120-531a-abeb-b226675cb22f","stable_key":"22527305-af1f-536a-b419-7e73f08cc3ec:luteolin-abcg2-blockade","predicate":"inhibition_retains","statement":"Ko143 inhibition of ABCG2 reduced luteolin-monoglucuronide efflux and increased intracellular retention.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"2809684d-33c4-5e5a-8764-7ed113051f93","mechanism_event_label":"Blocking export changes where metabolites accumulate.","subject":{"id":"a52e10c2-fd56-564b-8c05-27e9fce27cd6","slug":"abcg2","display_name":"Human ABCG2 / breast cancer resistance protein","entity_type_key":"protein"},"object":{"id":"f0186989-65b0-5f7a-95d9-d25a7789222b","slug":"luteolin-monoglucuronides","display_name":"Luteolin monoglucuronides, position unresolved in study","entity_type_key":"chemical_species"},"evidence_count":1,"mechanism_event":{"id":"2809684d-33c4-5e5a-8764-7ed113051f93","stable_key":"22527305-af1f-536a-b419-7e73f08cc3ec:luteolin-abcg2-blockade-event","event_type":"observed_relationship","label":"Blocking export changes where metabolites accumulate.","description":"Ko143 inhibition of ABCG2 reduced luteolin-monoglucuronide efflux and increased intracellular retention.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"a52e10c2-fd56-564b-8c05-27e9fce27cd6","slug":"abcg2","display_name":"Human ABCG2 / breast cancer resistance protein","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"f0186989-65b0-5f7a-95d9-d25a7789222b","slug":"luteolin-monoglucuronides","display_name":"Luteolin monoglucuronides, position unresolved in study","entity_type_key":"chemical_species"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"80472c4b-ecc2-52e3-a766-f8463294774f","slug":"luteolin","display_name":"Luteolin / 3′,4′,5,7-tetrahydroxyflavone","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"3249c76e-5379-5540-9d6b-9ad0de95d29b","slug":"luteolin-3-prime-o-glucuronide","display_name":"Luteolin 3′-O-glucuronide","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"d9e8bb8e-6e62-58b1-982c-c54273d650ab","slug":"luteolin-4-prime-o-glucuronide","display_name":"Luteolin 4′-O-glucuronide","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"4afd87a9-44dd-5774-8348-3dc09cde3e2a","slug":"luteolin-7-o-glucuronide","display_name":"Luteolin 7-O-glucuronide","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""},{"entity":{"id":"b466fd24-250f-566c-801d-7e607ef4179d","slug":"luteolin-3-4-prime-diglucuronide","display_name":"Luteolin 3′,4′-diglucuronide","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":6,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"UGT1A9-expressing human HeLa cells.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Pharmacological inhibition; diglucuronide compensation was proposed, not proven in patients.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Luteolin collection; molecular form, preparation, species, exposure and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"luteolin","display_name":"Luteolin / 3′,4′,5,7-tetrahydroxyflavone","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Blocking export changes where metabolites accumulate.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Breast cancer resistance protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing UDP-glucuronosyltransferase 1A9. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24092055/ · DOI 10.1007/s11095-013-1207-0","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"0341d3ca-9bb6-5081-afaa-7e841c41a6e3","evidence_kind":"source_excerpt","locator":"Lines 84-90","start_line":84,"end_line":90,"excerpt":"## luteolin-abcg2-blockade\nBlocking export changes where metabolites accumulate.\nKo143 inhibition of ABCG2 reduced luteolin-monoglucuronide efflux and increased intracellular retention.\nModel: UGT1A9-expressing human HeLa cells.\nLimitations: Pharmacological inhibition; diglucuronide compensation was proposed, not proven in patients.\nEvidence access: Primary abstract\nBreast cancer resistance protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing UDP-glucuronosyltransferase 1A9. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24092055/ · DOI 10.1007/s11095-013-1207-0","model_system":"UGT1A9-expressing human HeLa cells.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"26337a08-5cee-5cee-900e-e6d3e26ac6e4","stable_key":"import-22527305-af1f-536a-b419-7e73f08cc3ec","title":"Luteolin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"fd6ea0b1cef8d1c9965270494bfa815de14f679044f0b5d5d7bbf4904630ad76","revision_id":"c9a3dd80-c7e6-5fb4-bc91-8db265e7c8de","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}